Resatorvid, a selective TLR-4 antagonist, has been reported to exert a neuroprotective effect by decreasing inflammation in various experimental models of cerebral injury such as traumatic brain injury, cerebral I/R injury, and intracerebral hemorrhage-induced brain injury [11,21,22]. The gene discussed is TLR4; the disease is brain injury.